Amphastar Pharmaceuticals (AMPH) EBT Growth (3y) (2016 - 2026)
Amphastar Pharmaceuticals (AMPH) EBT Growth (3y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | 21.00% |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn | -0.23% |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn | 1.19% |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn | 3.60% |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -29.91% |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | 10.08% |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 39.40% |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Amphastar Pharmaceuticals | 936.60 Mn | 646.48 Mn | 93.47 Mn | 5.52% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5.52% |
| Mar 31, 2026 | -33.10% |
| Dec 31, 2025 | -8.21% |
| Sep 30, 2025 | -1.62% |
| Jun 30, 2025 | 19.33% |
| Mar 31, 2025 | 2.06% |
| Dec 31, 2024 | 17.41% |
| Sep 30, 2024 | 8.20% |
| Jun 30, 2024 | 52.32% |
| Mar 31, 2024 | 110.76% |
| Dec 31, 2023 | -175.24% |
| Sep 30, 2023 | 107.94% |
| Jun 30, 2023 | 187.70% |
| Mar 31, 2023 | 79.49% |
| Dec 31, 2022 | 31.73% |
| Sep 30, 2022 | 142.63% |
| Jun 30, 2022 | -27.64% |
| Mar 31, 2022 | 115.38% |
| Dec 31, 2021 | 258.60% |
| Sep 30, 2021 | 144.55% |